RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

<<Going to be at least a month or two before we've got anything of substance to discuss about Cortex.>>

Probably true. If they were confident of a deal--and receipt of money--before mid-April, they would not have downsized.

One thing that has not been noted, and is perhaps important, is that the downsizing did not eliminate Les Street. Street may be the most immediately employable person at Cortex: even in a time of constriction, really good chemists are sought after. Had they laid him off, he'd have been elsewhere quite quickly. So why would Cortex want to keep him (and why would he want to stay?) if they were about to expire? After all, his role would be to produce improved chemical variations of low-impacts, either for Cortex alone or for a partnership---and to continue working on the high-impact program. Cortex would not have kept him and his salary if they were just playing out the string, and he probably would have looked to exit. They expect that there will be work for him to do at Cortex, which means they are planning to be moving ahead, not disappearing.


NeuroInvestment